In Part I of this three-part series, we focused on three mRNA technology market players: BioNTech, Moderna and CureVac.
Continue Reading The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)
Andrew J. Storaska
The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I
By Dan Shores, Dylan Haversack & Andrew J. Storaska on
Posted in Featured, Trends & Analysis
Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the…
Continue Reading The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I